Topic: B117

Pfizer indicated a 90-day window for modifying vaccines to address new variants. Questions are raised regarding whether these updates will require full clinical trials or if they will be handled like annual flu shots using smaller immunogenicity studies.

The rebranding of the B117 coronavirus strain as the Delta variant is characterized as a strategic move to increase public concern. Media reports from the United Kingdom and India emphasize the variant's rapid spread among younger populations, which President Joe Biden has used as a justification for youth vaccination. Despite reports of asymptomatic spread, countries like Canada and the UK continue to maintain or extend lockdown restrictions.

Epidemiologist Michael Osterholm warns of an impending "tsunami" of COVID-19 cases driven by the B117 variant, specifically targeting the Midwest and Northeast. The hosts criticize his repeated predictions of surges and his calls for continued restrictions despite the vaccine rollout.

Thailand has successfully trained dogs to sniff out COVID-19 infections. Conversely, researchers at Texas A&M University have detected the B117 variant in domestic cats and dogs. The conflicting narratives regarding pets as either diagnostic tools or potential vectors for the virus are highlighted as a point of scientific confusion.

Governor Greg Abbott's decision to lift mask mandates and capacity restrictions in Texas faces criticism from local officials and health experts. Austin Mayor Steve Adler refused to comply with the state's deadline, leading to a legal standoff between the city and the state. Dr. Michael Osterholm warns of a "fourth wave" driven by the B-117 variant, describing the current situation as the "eye of the hurricane" despite falling case rates.

The Mayor of Miami Beach expressed concern over a potential COVID-19 surge driven by the B117 variant and an influx of spring break tourists arriving on discounted flights. Local officials worry that open bars and large gatherings will lead to super-spreader events similar to those seen in early 2020.

Former FDA Commissioner and Pfizer board member Scott Gottlieb warned that cities like Miami and San Diego are at high risk for regional epidemics of the B117 variant. He noted that the FDA is developing a regulatory framework to allow vaccine boosters to be licensed based on small patient trials. This "platform" approach would allow pharmaceutical companies to quickly adapt vaccines to new strains without extensive long-term testing.